Stellus Capital Q2 EPS meets at $0.26, sales miss estimate
Stellus Capital met Q2 EPS estimates at $0.26 but missed sales forecasts with $22.3 million in revenue, down 13.2% YoY. Unrealized appreciation boosted net assets despite lower investment income.

*this image is generated using AI for illustrative purposes only.
Stellus Capital Investment Corporation (NYSE: SCM) reported second-quarter fiscal 2027 earnings per share of $0.26, meeting analyst consensus estimates despite a 25.71% year-over-year decline from $0.35 in the prior period. However, the Houston-based business development company missed revenue expectations, with quarterly sales of $22.303 million falling short of the $25.139 million consensus by 11.28%. This represents a 13.20% drop from $25.696 million in the same quarter last year, reflecting broader headwinds in the lower middle-market lending environment.
The divergence between earnings performance and revenue misses highlights the impact of cost controls and portfolio yield compression. While net investment income declined to $7.53 million ($0.26 per share) from $9.56 million ($0.34 per share) a year ago, gross operating expenses were reduced to $14.8 million from $17.1 million. Base management fees totaled $4.4 million, and income incentive fees dropped significantly to $0.2 million from $2.2 million due to waivers under the Investment Advisory Agreement.
Financial Highlights
| Metric | Q2 FY27 Amount | Q2 FY27 Per Share | Q2 FY26 Amount | Q2 FY26 Per Share |
|---|---|---|---|---|
| Net investment income | $7.53 million | $0.26 | $9.56 million | $0.34 |
| Core net investment income | $7.56 million | $0.26 | $9.99 million | $0.35 |
| Total realized income | $0.29 million | $0.01 | $8.68 million | $0.31 |
| Distributions | ($9.80 million) | ($0.34) | ($11.36 million) | ($0.40) |
| Net increase in net assets | $16.21 million | $0.56 | $10.15 million | $0.36 |
Investment income for the three months ended June 30, 2026, totaled $22.3 million, aligning with the reported sales figure that missed analyst projections. The shortfall in revenue was offset by significant unrealized appreciation, which surged to $15.9 million from $1.4 million in the prior year period. This appreciation more than compensated for a net realized loss of $7.2 million on investments, driving a higher net increase in net assets resulting from operations of $16.2 million compared to $10.1 million in the same period last year.
Portfolio Activity and Yield
Stellus funded $18 million of new investments and received $49 million in repayments during the quarter, resulting in a total portfolio of $968 million at fair value. The weighted average yield of debt and other income-producing investments was 9.0%, down from 9.3% at December 31, 2025. The weighted average yield of total investments was 8.4%, compared to 8.7% at the end of the previous fiscal year. The portfolio consists of 116 investments across various sectors, including healthcare services, manufacturing, and technology.
| Portfolio Metric | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Investments at fair value | $968.2 million | $1,007.6 million |
| Total assets | $982.1 million | $1,041.3 million |
| Net assets | $367.0 million | $371.2 million |
| Shares outstanding | 28,672,911 | 28,947,254 |
| Net asset value per share | $12.80 | $12.82 |
What the Numbers Show
The meeting of earnings estimates despite a revenue miss underscores the effectiveness of Stellus’s expense management strategies, particularly through fee waivers. However, the 11.28% revenue miss signals potential challenges in maintaining historical growth rates as portfolio yields compress. The reliance on unrealized gains to boost net asset increases suggests that current market valuations are favorable, but operational cash flow generation remains under pressure from lower interest income and reduced portfolio size.
Liquidity and Capital Resources
As of June 30, 2026, Stellus had $222.2 million in outstanding borrowings under its senior secured revolving credit facility, which has an aggregate commitment of up to $335.0 million with an accordion feature allowing expansion to $365.0 million. The company continues to execute its share repurchase program, having repurchased 467,317 shares at an average price of $8.50 per share since the program's inception in March 2026. During the second quarter alone, 274,343 shares were repurchased for approximately $2.4 million.
In a significant strategic development, Stellus received a license from the Small Business Administration (SBA) for its SBIC III subsidiary on July 14, 2026. This license allows the company to contribute $125.0 million of equity and draw up to $250.0 million of SBA-guaranteed debentures, subject to family of funds limits. This expansion of leverage capacity provides additional dry powder for future investments in the lower middle-market space.
How will the newly acquired SBA SBIC III license and its $250 million debenture capacity impact Stellus's future deployment strategy in the lower middle-market?
Can Stellus sustain its earnings per share targets if portfolio yield compression continues alongside the current trend of reduced incentive fee income?
What is the expected timeline for deploying the $125 million equity contribution into the SBIC III subsidiary, and how will this affect the parent company's liquidity?



























